Protection

Families are failing to protect themselves despite being more worried than ever by the rising cost of living and falling salaries, new research has found.

The Cancer Drugs Fund has led to a ‘devastating divide' in access to treatment between England and other home nations, according to a cancer charity.

The private healthcare market ‘may not be working well for consumers', the Office of Fair Trading (OFT) has said.

Unison has called for an immediate halt to the government's Health and Social Care Bill that will reform the NHS and highlighted fears that private patients may get priority.

More than 1,000 advisers are now writing protection business through Sesame Bankhall Group's panel following its launch last November, the network has announced.

Ageas Protect has almost doubled its income and nearly halved its loss over the first six months of the year.

Sue Elliott looks at recent developments in long-term care and asks what happens now.

The insurance industry made a total contribution of £10.4bn to the Exchequer, a report from the Association of British Insurers (ABI) and PWC has revealed.

The National Institute for Health and Clinical Excellence (NICE) has rejected another cancer drug for the NHS due to its cost.

The NHS exceeded all seven of its targets for cancer diagnosis and treatment during the last year, new data has revealed.